Top pharma group seeks postmortem on lobbying after drug pricing loss
Washington’s top pharmaceutical lobby is doing some self-reflection, commissioning a report that looks at its advocacy in the runup to its most consequential legislative loss in decades. Megan R. Wilson talks with Alice Miranda Ollstein about the upcoming report.
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Washington’s top pharmaceutical lobby is doing some self-reflection, commissioning a report that looks at its advocacy in the runup to its most consequential legislative loss in decades. Megan R. Wilson talks with Alice Miranda Ollstein about the upcoming report.
Learn more about your ad choices. Visit megaphone.fm/adchoices